Phlow Corp.

Product	Key Starting Materials (KSMs), Active Pharmaceutical Ingredients (APIs), and Finished Dose Forms (FDFs) for 15 critically important medicines
Description of Project	This contract was awarded to expand the production of KSMs, APIs, and FDFs for 15 medicines of critical importance to the U.S. health system at their state-of-the-art manufacturing ecosystem.
Unique Impact	Bolstering domestic production of critical medicines helps decrease supply chain vulnerabilities and reduces our reliance on foreign pharmaceutical companies, which currently supply more than 70% of the KSMs and APIs to the U.S.
Base Award Amount	$583.00
Category	Therapeutics Supplies and Raw Materials